Ahmet Sezer
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- CAR-T cell therapy research
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 34
- Cancer Immunotherapy and Biomarkers 12
- Inflammatory Biomarkers in Disease Prognosis 4
- Lung Cancer Research Studies 4
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Özgür Özyılkan (22 shared papers)Hüseyin Mertsoylu (19 shared papers)Fatih Köse (18 shared papers)Ali Ayberk Beşen (15 shared papers)Erkan Topkan (6 shared papers)Ahmet Taner Sümbül (16 shared papers)Uğur Selek (6 shared papers)Ahmet Küçük (5 shared papers)
- Journals
- Journal of Thoracic Oncology (6 papers)Annals of Oncology (6 papers)Medical Oncology (4 papers)Journal of Clinical Oncology (3 papers)Journal of Thoracic and Cardiovascular Surgery (3 papers)
- Partner nations
- TürkiyeUnited StatesUkraine
In The Last Decade
Ahmet Sezer
86 papers receiving 2.1k citations
Ahmet Sezer's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 767
- Immunology 295
- Pharmaceutical Science 66
- Cancer Research 145
Countries citing papers authored by Ahmet Sezer
This map shows the geographic impact of Ahmet Sezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Sezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Sezer more than expected).
Fields of papers citing papers by Ahmet Sezer
This network shows the impact of papers produced by Ahmet Sezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Sezer. The network helps show where Ahmet Sezer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ahmet Sezer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial Hit paper breakdown → | 2021 | 602 |
| 2 | Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study Hit paper breakdown → | 2019 | 565 |
| 3 | 1995 | 88 | |
| 4 | Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer Hit paper breakdown → | 2025 | 63 |
| 5 | 2023 | 60 | |
| 6 | 2014 | 54 | |
| 7 | 2021 | 36 | |
| 8 | 2023 | 32 | |
| 9 | 2020 | 29 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 28 | |
| 12 | 2010 | 27 | |
| 13 | 2014 | 22 | |
| 14 | 2024 | 22 | |
| 15 | Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience. | 2011 | 19 |
| 16 | 2019 | 19 | |
| 17 | 2023 | 18 | |
| 18 | 2009 | 17 | |
| 19 | 2018 | 17 | |
| 20 | 2023 | 15 |
About Ahmet Sezer
Ahmet Sezer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Genetics, having authored 94 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Lung Cancer Research Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Heart Failure Treatment and Management (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (1.0k citations), Pulmonary and Respiratory Medicine (767 citations), Immunology (295 citations), Pharmaceutical Science (66 citations) and Cancer Research (145 citations). Ahmet Sezer has collaborated with scholars based in Türkiye, United States and Ukraine. Frequent co-authors include Özgür Özyılkan, Hüseyin Mertsoylu, Fatih Köse, Ali Ayberk Beşen, Erkan Topkan, Ahmet Taner Sümbül, Uğur Selek, Ahmet Küçük, Umut Dişel and Yurday Özdemir. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Medical Oncology, Journal of Clinical Oncology and Journal of Thoracic and Cardiovascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.